Healthspan Review · Evidence Review

The True Value of Vigorous Exercise

Wearable device data from 73,485 adults overturns the longstanding 1:2 ratio between vigorous and moderate physical activity — and the implications for longevity are substantial.

Rob Aldwinckle, BMBS FRCA · April 2026 · Evidence Review
Bottom Line

The WHO-endorsed convention that 1 minute of vigorous physical activity (VPA) equals 2 minutes of moderate physical activity (MPA) is almost certainly wrong. Accelerometer data from 73,485 UK adults suggests the true ratio is closer to 1:4 for all-cause mortality and as high as 1:9 for type 2 diabetes risk reduction. Vigorous activity is 2–4 times more time-efficient than previously assumed.

Evidence Grade: Oxford CEBM Level 2b (prospective cohort, device-measured exposure). Moderate-High credibility. Awaits replication in independent cohorts.

Source: Biswas RK, Ahmadi MN, Bauman A, Milton K, Koemel NA, Stamatakis E. Nature Communications 2025; 16: 8315.

Key Findings

The Conventional 1:2 Ratio Is Substantially Wrong

Current WHO guidelines recommend 150–300 minutes per week of moderate-intensity or 75–150 minutes of vigorous-intensity physical activity, reflecting a 1:2 equivalence ratio derived from MET-based energy expenditure calculations and self-reported data. This study used wrist-worn accelerometer data with a validated machine-learning intensity classifier to objectively quantify the actual health equivalence between intensity levels for the first time.

The results are striking. Across all cardiometabolic outcomes, vigorous activity was far more time-efficient than the conventional ratio implies. The equivalence varied by outcome, with the strongest differential seen for type 2 diabetes (1:9.4) and CVD mortality (1:7.8), and a more modest — but still doubled — ratio for all-cause mortality (1:4.1).

Health Outcome VPA : MPA (New) VPA : LPA Old Ratio
All-Cause Mortality 1 : 4.1 1 : 53 1 : 2
CVD Mortality 1 : 7.8 1 : 73 1 : 2
MACE 1 : 5.4 1 : 86 1 : 2
Type 2 Diabetes 1 : 9.4 1 : 94 1 : 2
Cancer Mortality 1 : 3.5 1 : 156 1 : 2
Cancer Incidence 1 : 1.6 1 : 5 1 : 2

VPA = Vigorous Physical Activity; MPA = Moderate Physical Activity; LPA = Light Physical Activity; MACE = Major Adverse Cardiovascular Events. Old ratio reflects the WHO/guideline convention based on self-reported data. New ratios represent median equivalence across 5–35% risk reduction (Biswas et al. 2025).

Vigorous Activity Shows the Steepest Dose-Response

VPA demonstrated pronounced, nearly linear dose-response gradients for all non-cancer outcomes. MPA showed a steep inverse relationship up to approximately 30 minutes per day, after which benefits plateaued. LPA exhibited only subtle risk reductions for all-cause mortality and type 2 diabetes, with no statistically significant associations for MACE, CVD mortality, or cancer outcomes.

Critically, even the largest daily volumes of LPA could not replicate the risk reductions achievable through moderate or vigorous intensity activity. The LPA equivalence ratios (53–156 minutes per VPA minute) are derived from very weak dose-response curves and should be interpreted as mathematical constructs, not clinically actionable substitution ratios.

Cancer Outcomes Are Notably Different

The equivalence ratios for cancer outcomes were substantially lower than for cardiometabolic endpoints. Cancer mortality showed a 1:3.5 VPA:MPA ratio, while cancer incidence showed only 1:1.6 — much closer to the old 1:2 convention. This likely reflects weaker VPA dose-response curves for cancer, suggesting that the mechanisms driving cardiometabolic benefits may differ from those mediating cancer risk reduction.

Study Design

Cohort: 73,485 adults from the UK Biobank (mean age 61.6 years, 56.4% female) who wore a wrist-mounted Axivity AX3 accelerometer continuously for 7 days between 2013 and 2015.

Follow-up: Mean 8.0 years, yielding 585,313 person-years for all-cause mortality. Events included 2,675 all-cause deaths, 545 CVD deaths, 2,359 MACE events, 1,836 type 2 diabetes diagnoses, and 538 PA-related cancer deaths.

Intensity classification: A validated two-stage Random Forest machine-learning classifier processed raw acceleration signals in 10-second windows — substantially more granular than questionnaire methods, which typically require activity bouts of 10–15 minutes or longer.

Statistics: Cox proportional hazards for all-cause mortality; Fine-Gray subdistribution hazard models for disease-specific outcomes (competing risks). Restricted cubic splines with knots at 10th, 50th, and 90th percentiles. Equivalence derived by comparing intensity values needed for the same 5–35% risk reduction, standardised to 1 minute of VPA.

Critical Appraisal

Strengths

Novel Question
First study to systematically quantify per-minute intensity equivalence using device data against hard clinical endpoints, rather than surrogate markers like VO₂max or lipid profiles.
Validated ML Classifier
The Random Forest activity classifier operates at 10-second resolution and has been validated across multiple publications (Ahmadi et al., Eur Heart J 2022; Stamatakis et al., Nat Med 2022).
Competing-Risk Models
Fine-Gray subdistribution hazards for disease-specific outcomes correctly account for competing mortality — an important methodological choice often neglected.
Triangulation with RCTs
The population-level VPA:MPA ratios (1:4 to 1:9) bracket the 1:7 to 1:13 ratios observed in supervised HIIT vs MICT trials for surrogate cardiometabolic outcomes.

Limitations

Single Cohort, Single Week
All data derive from one 7-day accelerometry period in one cohort (UK Biobank). Reproducibility ICCs range from 0.58–0.75 — moderate-to-good, but a single week is an imperfect proxy for long-term behaviour.
Healthy Volunteer Bias
The UK Biobank had a 5.5% response rate. Accelerometry participants were healthier, better educated, and less likely to smoke. While post-stratification suggests relative associations hold, specific ratios may not generalise.
5.5-Year Covariate Gap
Baseline covariates (BMI, medications, smoking, diet) were measured a median of 5.5 years before accelerometry. Time-varying confounders cannot be excluded.
Observational Design
Causal inference is not possible. The equivalence ratios reflect associations, not proven substitution effects. Unmeasured confounding cannot be ruled out.
LPA Ratios Are Fragile
LPA dose-response was weak and non-significant beyond 10–15% risk reduction. The large equivalence numbers (53–156 min) are mathematical artefacts from near-null effects, not actionable substitution ratios.
Conflict of Interest
Senior author holds equity in Complement 1, a company whose products relate to physical activity. The paper’s recommendation that wearable algorithms be recalibrated is directly relevant to this interest.

Evidence Context

This study sits within a productive programme from the Sydney Mackenzie Wearables Research Hub, all drawing on the same UK Biobank accelerometry sub-cohort and Random Forest classifier:

The consistency across studies is reassuring for internal validity. However, the same cohort-specific biases (5.5% response rate, healthy-volunteer effect, single 7-day wear window, 5.5-year covariate lag) propagate through the entire evidence base.

Practical Implications for Longevity
  1. Vigorous activity is the highest-yield time investment. For cardiometabolic outcomes, each minute of vigorous effort delivers 4–9 times the risk-reduction of moderate effort. If you are time-constrained, prioritise intensity.
  2. The old 1:2 guideline ratio undervalues vigorous activity. Current wearable algorithms (Google Fit Heart Points, Apple Activity Rings) likely underweight vigorous minutes. Treat your vigorous minutes as worth considerably more than the app suggests.
  3. Brief vigorous bursts count. You do not need sustained 30-minute sessions. Short bursts embedded in daily life — stair climbing, brisk inclines, cycling sprints — accumulate meaningful health benefits. This aligns with the entire VILPA evidence base.
  4. Light activity is not a substitute, but it is not useless. LPA showed modest associations with all-cause mortality and T2DM, but the dose-response was weak. Use light activity as a sedentary-time replacement, not an exercise substitute.
  5. These are best-available estimates, not settled constants. The specific ratios will shift as replication data accumulate from diverse populations. The directional finding — vigorous is substantially more efficient than moderate — is robust.

References

  1. Biswas RK, Ahmadi MN, Bauman A, Milton K, Koemel NA, Stamatakis E. Wearable device-based health equivalence of different physical activity intensities against mortality, cardiometabolic disease, and cancer. Nat Commun. 2025;16:8315.
  2. Bull FC, Al-Ansari SS, Biddle S, et al. World Health Organization 2020 guidelines on physical activity and sedentary behaviour. Br J Sports Med. 2020;54(24):1451–1462.
  3. Stamatakis E, Ahmadi MN, Gill JMR, et al. Association of wearable device-measured vigorous intermittent lifestyle physical activity with mortality. Nat Med. 2022;28(12):2521–2529.
  4. Ahmadi MN, Clare PJ, Katzmarzyk PT, del Pozo Cruz B, Lee IM, Stamatakis E. Vigorous physical activity, incident heart disease, and cancer: how little is enough? Eur Heart J. 2022;43(46):4801–4814.
  5. Ahmadi MN, Hamer M, Gill JM, et al. Brief bouts of device-measured intermittent lifestyle physical activity and its association with major adverse cardiovascular events and mortality. Lancet Public Health. 2023;8(10):e800–e810.
  6. Stamatakis E, Ahmadi MN, Biswas RK, et al. Vigorous intermittent lifestyle physical activity and cancer incidence among nonexercising adults. JAMA Oncol. 2023;9(9):1255–1259.
  7. Koemel NA, Ahmadi MN, Biswas RK, et al. Vigorous intermittent lifestyle physical activity (VILPA) and mortality risk among US adults: a wearables-based national cohort study. Int J Behav Nutr Phys Act. 2026.
  8. Mattioni Maturana F, Martus P, Zipfel S, Nieß AM. Effectiveness of HIIE versus MICT in improving cardiometabolic risk factors. Med Sci Sports Exerc. 2021;53(3):559–573.
  9. Wewege M, van den Berg R, Ward RE, Keech A. The effects of HIIT vs. MICT on body composition in overweight and obese adults. Obes Rev. 2017;18(6):635–646.
  10. Ekelund U, Tarp J, Steene-Johannessen J, et al. Dose-response associations between accelerometry measured physical activity and sedentary time and all cause mortality. BMJ. 2019;366:l4570.
  11. Wang Y, Nie J, Ferrari G, Rey-Lopez JP, Rezende LFM. Association of physical activity intensity with mortality. JAMA Intern Med. 2021;181(2):203.
  12. Stamatakis E, Ahmadi MN, Friedenreich CM, et al. Is cohort representativeness passé? Post-stratified associations of lifestyle risk factors with mortality in the UK Biobank. Epidemiology. 2021;32(2):179–188.